Alternatives to Orchard Therapeutics

Orchard Therapeutics is a Biotech tool: gene therapy company developing treatments for rare inherited diseases. Here are the 60 closest alternatives, compared on pricing, features and what real users say.

Orchard Therapeutics profile More Biotech alternatives

The 20 closest Biotech companies to Orchard Therapeutics

Spark Therapeutics
Not rated
A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
Visit site
Bluebird Bio
Not rated
Gene therapy company developing transformative treatments for severe genetic diseases.
Visit site
Rocket Pharmaceuticals
Not rated
A biotechnology company developing genetic therapies for rare disorders.
Visit site
Adaptive Biotechnologies
Not rated
Leveraging the adaptive immune system to diagnose and treat disease.
Visit site
BeiGene
Not rated
A global oncology company developing and commercializing innovative cancer treatments.
Visit site
Lexeo Therapeutics
Not rated
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
Visit site
Caris Life Sciences
Not rated
Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Visit site
Harmony Biosciences Holdings
Not rated
Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.
Visit site
Guardant Health
Not rated
Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
Visit site
Amicus Therapeutics
Not rated
Biotechnology company focused on developing treatments for rare metabolic diseases.
Visit site
Cellcolabs
Not rated
AI-powered platform for personalized cell therapy development and manufacturing.
Visit site
Tenaya Therapeutics
Not rated
Biotechnology company developing gene therapies and regenerative medicine for heart disease.
Visit site
Regenxbio
Not rated
Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.
Visit site
BioLife Solutions
Not rated
Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.
Visit site
Integra Therapeutics
Not rated
Biotech company developing next-generation gene writing tools for advanced therapies.
Visit site
Avidity Biosciences
Not rated
Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
Visit site
Adaptam Therapeutics
Not rated
Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.
Visit site
Rezolute
Not rated
Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.
Visit site
Syantra
Not rated
A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.
Visit site
MacroGenics
Not rated
Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.
Visit site

Company	Rating	Visit
Spark TherapeuticsA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.	Not rated	Visit site
Bluebird BioGene therapy company developing transformative treatments for severe genetic diseases.	Not rated	Visit site
Rocket PharmaceuticalsA biotechnology company developing genetic therapies for rare disorders.	Not rated	Visit site
Adaptive BiotechnologiesLeveraging the adaptive immune system to diagnose and treat disease.	Not rated	Visit site
BeiGeneA global oncology company developing and commercializing innovative cancer treatments.	Not rated	Visit site
Lexeo TherapeuticsClinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.	Not rated	Visit site
Caris Life SciencesCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.	Not rated	Visit site
Harmony Biosciences HoldingsBiopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.	Not rated	Visit site
Guardant HealthGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.	Not rated	Visit site
Amicus TherapeuticsBiotechnology company focused on developing treatments for rare metabolic diseases.	Not rated	Visit site
CellcolabsAI-powered platform for personalized cell therapy development and manufacturing.	Not rated	Visit site
Tenaya TherapeuticsBiotechnology company developing gene therapies and regenerative medicine for heart disease.	Not rated	Visit site
RegenxbioClinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.	Not rated	Visit site
BioLife SolutionsDevelops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.	Not rated	Visit site
Integra TherapeuticsBiotech company developing next-generation gene writing tools for advanced therapies.	Not rated	Visit site
Avidity BiosciencesClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.	Not rated	Visit site
Adaptam TherapeuticsDeveloping novel therapeutics for rare genetic diseases with a focus on protein degradation.	Not rated	Visit site
RezoluteBiopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.	Not rated	Visit site
SyantraA precision biotechnology company developing a blood-based platform for early cancer detection and treatment.	Not rated	Visit site
MacroGenicsBiopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.	Not rated	Visit site

Showing the next 20 closest matches. See the rest on the Orchard Therapeutics profile.

Sponsored rows are paid and labelled. Advertise on this page